Sagimet Biosciences Inc. (SGMT) Market Cap
- 2024-11-08: Market Cap $182.21M.
- 2024-08-09: Market Cap $84.36M.
- 2024-05-10: Market Cap $134.95M.
- 2023-11-09: Market Cap $59.85M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2023-08-16 to 2024-11-08
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|---|
| 2024-11-08 | $182.21M |
| 2024-08-09 | $84.36M |
| 2024-05-10 | $134.95M |
| 2023-11-09 | $59.85M |
| 2023-08-16 | $309.43M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |